Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorUniversity Hospital, Brest

About this trial

In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult (Age >18 years old)

A suspected or confirmed infection

Persisting hypotension, despite adequate fluid resuscitation, requiring vasopressor to maintain a Mean Arterial Pressure (MAP) ≥ 65 mmHg

Lactate level > 2 mmol/l

Disqualifiers

Admission in ICU for more than 3 days

Refusal to participate

Moribund patients

Decision of therapeutic withdrawal

Trial population

Adult patients admitted in ICU for septic shock

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Changes in daily body weight

Evaluation of correlation between daily body weight and thoracic fluid content

Time frame
Daily, during the first 10 days
2

Changes in extra vascular lung water

Evaluation of correlation between extra vascular lung water and thoracic fluid content

Time frame
Daily, during the first 10 days
3

Changes in daily fluid balance

Evaluation of correlation between fluid balance and thoracic fluid content

Time frame
Daily, during the first 10 days

Secondary outcomes

1

Length of ICU stay

Number of day from admission to ICU leaving

Time frame
during ICU stay (up to 10 days)
2

Length of hospital stay

Number of day from admission to hospital leaving

Time frame
during hospital stay (up to 10 days)
3

Ventilator free days at Day 28

Number of day alive without mechanical from ICU admission to Day 28

Time frame
Day 28
4

Mortality at Day 28

Survival (Yes/No)

Time frame
Day 28

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.